nypozi txid

Generic: filgrastim-txid

Labeler: tanvex biopharma usa, inc.
NDC Directory HUMAN PRESCRIPTION DRUG BLA Inactive Finished

Drug Facts

Product Profile

Brand Name nypozi txid
Generic Name filgrastim-txid
Labeler tanvex biopharma usa, inc.
Dosage Form INJECTION
Routes
INTRAVENOUS SUBCUTANEOUS
Active Ingredients

filgrastim 300 ug/300ug

Manufacturer
Tanvex BioPharma USA, Inc.

Identifiers & Regulatory

Product NDC 72374-101
Product ID 72374-101_23d9f1d4-c25a-45fb-8095-986c659cb532
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category BLA
Application Number BLA761126
Listing Expiration 2027-12-31
Marketing Start 2025-09-23

Pharmacologic Class

Established (EPC)
leukocyte growth factor [epc]
Chemical Structure
granulocyte colony-stimulating factor [cs]
Physiologic Effect
increased myeloid cell production [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 72374101
Hyphenated Format 72374-101

Supplemental Identifiers

RxCUI
2700369 2700376 2700378 2700379
UNII
PVI5M0M1GW
NUI
M0024696 N0000009451 N0000175666

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name nypozi txid (source: ndc)
Generic Name filgrastim-txid (source: ndc)
Application Number BLA761126 (source: ndc)
Routes
INTRAVENOUS SUBCUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 300 ug/300ug
source: ndc
Packaging
  • 1 SYRINGE, GLASS in 1 CARTON (72374-101-01) / 300 ug in 1 SYRINGE, GLASS
  • 10 SYRINGE, GLASS in 1 CARTON (72374-101-10) / 300 ug in 1 SYRINGE, GLASS
source: ndc

Packages (2)

Ingredients (1)

filgrastim (300 ug/300ug)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "23d9f1d4-c25a-45fb-8095-986c659cb532", "openfda": {"nui": ["M0024696", "N0000009451", "N0000175666"], "unii": ["PVI5M0M1GW"], "rxcui": ["2700369", "2700376", "2700378", "2700379"], "spl_set_id": ["89092bb8-6a20-e23e-e053-2a95a90aa750"], "pharm_class_cs": ["Granulocyte Colony-Stimulating Factor [CS]"], "pharm_class_pe": ["Increased Myeloid Cell Production [PE]"], "pharm_class_epc": ["Leukocyte Growth Factor [EPC]"], "manufacturer_name": ["Tanvex BioPharma USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 SYRINGE, GLASS in 1 CARTON (72374-101-01)  / 300 ug in 1 SYRINGE, GLASS", "package_ndc": "72374-101-01", "marketing_start_date": "20250923"}, {"sample": false, "description": "10 SYRINGE, GLASS in 1 CARTON (72374-101-10)  / 300 ug in 1 SYRINGE, GLASS", "package_ndc": "72374-101-10", "marketing_start_date": "20250923"}], "brand_name": "NYPOZI txid", "product_id": "72374-101_23d9f1d4-c25a-45fb-8095-986c659cb532", "dosage_form": "INJECTION", "pharm_class": ["Granulocyte Colony-Stimulating Factor [CS]", "Increased Myeloid Cell Production [PE]", "Leukocyte Growth Factor [EPC]"], "product_ndc": "72374-101", "generic_name": "filgrastim-txid", "labeler_name": "Tanvex BioPharma USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NYPOZI", "brand_name_suffix": "txid", "active_ingredients": [{"name": "FILGRASTIM", "strength": "300 ug/300ug"}], "application_number": "BLA761126", "marketing_category": "BLA", "marketing_start_date": "20250923", "listing_expiration_date": "20271231"}